In focus · trending topic

High Mobility Group

1 stories · following the connections

PROVECTUS BIOPHARMACEUTICALS RECEIVES THIRD CANCER COMBINATION THERAPY PATENT FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE

By Nasdaq OMXDec 14, 2017, 11:00 AM UTC